Her scientific interests lie mostly in Neuroscience, Dopamine, Striatum, Dopaminergic and Neurotransmission. Her research investigates the connection with Dopamine and areas like Neurotransmitter which intersect with concerns in Cholinergic neuron and Dopamine transporter. Her Striatum research includes elements of Basal ganglia and Nicotine.
Her study in Dopaminergic is interdisciplinary in nature, drawing from both Parkinson's disease, Alpha-synuclein, Neurodegeneration and Cholinergic. Her Neurotransmission study integrates concerns from other disciplines, such as Nerve net, Substantia nigra, Nucleus accumbens, Biophysics and Patch clamp. Her Nucleus accumbens study incorporates themes from Ventral tegmental area, Nicotinic agonist and Acetylcholine receptor.
The scientist’s investigation covers issues in Dopamine, Neuroscience, Striatum, Substantia nigra and Dopaminergic. Her Dopamine research includes themes of Neurotransmission and Neurotransmitter. Her studies in Neuroscience integrate themes in fields like Acetylcholine and Nicotinic agonist.
Her Striatum research is multidisciplinary, incorporating perspectives in Basal ganglia, Biophysics, Tonic and Putamen. The various areas that Stephanie J. Cragg examines in her Substantia nigra study include Isamoltane, Autoreceptor and Ventral tegmental area. She interconnects Neurodegeneration, Postsynaptic potential and Alpha-synuclein in the investigation of issues within Dopaminergic.
Stephanie J. Cragg spends much of her time researching Dopamine, Striatum, Neuroscience, Parkinson's disease and Dopamine transporter. Her work on Substantia nigra as part of her general Dopamine study is frequently connected to Downregulation and upregulation, thereby bridging the divide between different branches of science. The Substantia nigra study combines topics in areas such as Neurotransmission and Alpha-synuclein.
Her research on Striatum frequently links to adjacent areas such as Dopaminergic. Her Neuroscience research integrates issues from Neuropeptide and GABAB receptor, GABAA receptor. Her Dopamine transporter research is multidisciplinary, incorporating elements of Facilitation, Gating, Function and Striatal dopamine.
Stephanie J. Cragg mostly deals with Dopamine, Neuroscience, Striatum, Inhibitory postsynaptic potential and Depolarization. Her primary area of study in Dopamine is in the field of Striatal dopamine. Her work deals with themes such as Facilitation, Dopamine transporter and Gating, which intersect with Striatal dopamine.
Stephanie J. Cragg has included themes like Receptor, GABAB receptor and Stimulation in her Inhibitory postsynaptic potential study. Her research in Depolarization intersects with topics in Neuropeptide, Growth factor, Neuron and Midbrain. Her work deals with themes such as Substantia nigra, Parkinson's disease, Pars compacta, Neurotransmission and Pathology, which intersect with Synapse.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Striatal Dopamine Release Is Triggered by Synchronized Activity in Cholinergic Interneurons
Sarah Threlfell;Tatjana Lalic;Nicola J. Platt;Katie A. Jennings.
Neuron (2012)
Nicotine amplifies reward-related dopamine signals in striatum.
Margaret E Rice;Stephanie J Cragg.
Nature Neuroscience (2004)
DAncing past the DAT at a DA synapse.
Stephanie J. Cragg;Margaret E. Rice.
Trends in Neurosciences (2004)
Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway.
Margaret E. Rice;Stephanie J. Cragg.
Brain Research Reviews (2008)
α-Synuclein and dopamine at the crossroads of Parkinson's disease
Lara Lourenço Venda;Stephanie J. Cragg;Vladimir L. Buchman;Richard Wade-Martins.
Trends in Neurosciences (2010)
Dopamine receptors - physiological understanding to therapeutic intervention potential
Gérard Emilien;Jean-Marie Maloteaux;Muriel Geurts;Klaas Hoogenberg.
Pharmacology & Therapeutics (1999)
Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model
S Janezic;S Threlfell;P D Dodson;M J Dowie.
Proceedings of the National Academy of Sciences of the United States of America (2013)
Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission
R Exley;S J Cragg.
British Journal of Pharmacology (2008)
Dopamine release in the basal ganglia
Margaret E. Rice;Jyoti C. Patel;Stephanie J. Cragg.
Neuroscience (2011)
Striatal dopamine neurotransmission: regulation of release and uptake.
David Sulzer;Stephanie J. Cragg;Margaret E. Rice.
Basal ganglia (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Oxford
University of Oxford
New York University
University of Oxford
University of Oxford
University of Utah
Institut Pasteur
University of Oxford
University of Colorado Boulder
Columbia University
University of Göttingen
University of Edinburgh
Seoul National University
CUUR Diagnostics
Ministry of Natural Resources and Forestry
PSL University
University of St Andrews
ETH Zurich
University of Queensland
University of Arkansas for Medical Sciences
Hanyang University
Queen's University Belfast
University of Georgia
International Centre for Integrated Mountain Development
University of Arizona
University of Minnesota